32 results
John D. Clemens, Mohamed Saleh Jiddawi, Binod Sah, Mahesh K. Puri, Kamala Thriemer, Benedikt N. Ley, James Beard, Anna Lena Lopez, R. Hashim, Abdul A. Saleh, Frédérique Marodon, Valérie Perroud, Na Yoon Chang, Rita Reyburn, Said Mohammed Ali, Lorenz von Seidlein, Godwin Enwere, Ahmed Khatib, Jaqueline L. Deen, Mohammad Ali
PROBLEM: Field trials require extensive data preparation and complex logistics. The use of personal digital assistants (PDAs) can bypass many of the traditional steps that are necessary in a...
World Health Organization (WHO)
World Health Organization (WHO)
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each...
Global Task Force on Cholera Control
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a...
World Health Organization (WHO)
The Series “The Immunological Basis for immunization”, was initially developed in 1993 as a set of eight modules focusing on the vaccines included in the Expanded Programme on immunization...
World Health Organization (WHO)
The WHO Initiative for Vaccine Research organized a meeting jointly with the WHO Global Task Force on Cholera Control to examine the feasibility of a global stockpile for OCVs. Having major...
Teshome S et al.
Shanchol™, a WHO-prequalified oral cholera vaccine (OCV), has been used to control endemic cholera in Asia, as well as in emergencies and outbreaks elsewhere. The vaccine has not been used by...
World Health Organization (WHO)
The Controlled Temperature Chain Working Group (CTC) has recently developed a Strategic Roadmap for Priority Vaccines, which addresses supply and programmatic issues, aiming for CTC priority vaccines...
Marc Poncin et al.
Objective To describe the implementation and feasibility of an innovative mass vaccination strategy – based on single-dose oral cholera vaccine – to curb a cholera epidemic in a large urban...
Tomonori Nochi et al.
Capable of inducing antigen-specific immune responses in both systemic and mucosal compartments without the use of syringe and needle, mucosal vaccination is considered ideal for the global control...
Mohammad Ali et al.
Background: Pregnancy increases the risk of harmful effects from cholera for both mothers and their fetuses. A killed oral cholera vaccine, Shanchol (Shantha Biotechnics, Hydrabad, India), can...
Lucy A Parker et al.
Shortages of vaccines for epidemic diseases, such as cholera, meningitis, and yellow fever, have become common over the past decade, hampering efforts to control outbreaks through mass reactive...
Amber Hsiao, Sachin N Desai, Vittal Mogasale, Jean-Louis Excler, Laura Digilio
Improving water and sanitation is the preferred choice for cholera control in the long-term. Nevertheless, vaccination is an available too l that has been shown to be a cost‒effective option for...
Mogasale V et al.
Cholera is transmitted through the fecal-oral route, and humans are the natural host. It is caused by the ingestion of O1 and less commonly O139 serogroups of the Vibrio cholerae bacterium and...
Saha A et al.
Cholera\'s impact is greatest in resource-limited countries. In the last decade several large epidemics have led to a global push to improve and implement the tools for cholera prevention and...
Kimberly M. Thompson et al.
Managing the dynamics of vaccine supply and demand represents a significant challenge with very high stakes. Insufficient vaccine supplies can necessitate rationing, lead to preventable adverse...
Mohammad Ali et al.
Cholera is an important public health problem worldwide. Although most cholera infections are not detected, large cholera outbreaks, such as those seen in Haiti,1 Viet Nam2 and Zimbabwe3 in recent...
Iza Ciglenecki et al.
The number of reported cholera cases worldwide, as well as the frequency and scale of cholera epidemics, are increasing [1]. Traditional prevention measures, which focus on provision of safe water...
Wilfredo R. Matias et al.
Background The bivalent whole-cell (BivWC) oral cholera vaccine (Shanchol) is effective in preventing cholera. However, evaluations of immune responses following vaccination with BivWC have been...
Nicholas C. Grassly et al.
The reason for holding a meeting to discuss biological challenges to vaccines is simple: not all vaccines work equally well in all settings. This special issue reviews the performance of vaccines in...
Jong-Hoon Kim et al.
Background Impact evaluation of vaccination programs is necessary for making decisions to introduce oral cholera vaccines (OCVs) in cholera-endemic countries. Methods We analyzed data to forecast...
Victoria Koski-Karell et al.
Since the beginning of the cholera epidemic in Haiti 5 years ago, the prevalence of this deadly water-borne disease has fallen far below the initial rates registered during its explosive outset....
Kelias Phiri Msyamboza et al.
Despite some improvement in provision of safe drinking water, proper sanitation and hygiene promotion, cholera still remains a major public health problem in Malawi with outbreaks occurring almost...
Verma et al.
Cholera is a major global public health problem and remains an important threat in almost every developing country, especially in areas where population overcrowding and poor sanitation are common,...
Jacqueline Deen et al.
Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of licensed,...
Rita Reyburn et al.
The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long...
M. Pastor et al.
Cholera remains a huge public health problem. Although in 1894, the first cholera vaccination was reported, an ideal vaccine that meets all the requirements of the WHO has not yet been produced....
Rania A. Tohme et al.
In 2013, the first government-led oral cholera vaccination (OCV) campaign in Haiti was implemented in Petite Anse and Cerca Carvajal. To evaluate vaccination coverage, barriers to vaccination, and...
Mauricio L Barreto et al.
Despite pronounced reductions in the number of deaths due to infectious diseases over the past six decades, infectious diseases are still a public health problem in Brazil. In this report, we discuss...
John D. Clemens, Dipika Sur, Sujit K. Bhattacharya, Thomas F. Wierzba, Anna Lena Lopez, Jacqueline L. Deen, Byomkesh Manna, Suman Kanungo, Young Ae You, Mohammad Ali
BACKGROUND: Case-control studies have not been examined for their utility in assessing population-level vaccine protection in individually randomized trials. METHODS: We used the data of a...
Abdur Razzaque Sarker, Ashraful Islam Khan, Fahima Chowdhury, Amit Saha, Iqbal Ansary Khan, Firdausi Qadri, John David Clemens, Alejandro Cravioto, Ziaul Islam, Jahangir A. M. Khan
Cholera is a major global public health problem that causes both epidemic and endemic disease. The World Health Organization recommends oral cholera vaccines as a public health tool in addition to...
International Vaccine Institute
The costing tool enables the user to estimate the value of incremental (additional) resources required to add oral cholera vaccination campaigns to an existing immunization programme. The CholTool is...